This suggests a potential naming overlap or a misreference. No antibody-related data exists for "Y39B6A.34" in the reviewed materials.
Nomenclature Confusion:
Novel or Proprietary Compound:
If "Y39B6A.34" is a newly developed antibody, it may not yet be published in peer-reviewed literature or registered in public databases.
Typographical Error:
To resolve ambiguity, consider:
Cross-Referencing Databases:
Target-Specific Research:
Direct Communication with Researchers:
ZHP-4, encoded by gene Y39B6A.16 in C. elegans, is a paralog of ZHP-3 with significant predicted protein sequence similarity (13% identity and 23% similarity). Both proteins share structural features of the C3HC4-type RING finger domain characteristic of known SUMO E3 ligases. ZHP-4 is essential for crossover formation during meiosis, functioning at multiple distinct steps in the meiotic recombination process .
Methodologically, ZHP-4's role has been characterized through:
EMS screening for recessive nondisjunction mutants
Analysis of protein sequence similarity to identify functional domains
Generation and characterization of mutation alleles (vv96, vv103)
Cytological analysis of meiotic progression in mutant backgrounds
Multiple complementary approaches have been validated for ZHP-4 detection:
Antibody-based detection:
Custom antibodies raised against the C-terminal 123 amino acids
CRISPR-generated HA tag for immunodetection using commercial anti-HA antibodies
Visualization techniques:
For optimal results, researchers should standardize fixation protocols and antibody dilutions for each application, as sensitivity varies between detection methods.
ZHP-4 exhibits distinctive co-localization patterns with several key meiotic proteins:
ZHP-3: Complete co-localization is observed both along the SC in early pachytene and at the 5-7 crossover sites that emerge in late pachytene .
Axis proteins (HTP-3): ZHP-4 localizes to synapsed chromosome axes marked by HTP-3 .
Crossover markers: In wild-type, ZHP-4 eventually co-localizes with crossover-specific proteins like COSA-1 and MSH-5 at the 5-7 designated crossover sites .
For co-localization studies, sequential or simultaneous immunostaining protocols may be employed depending on antibody compatibility. Controls for antibody specificity, including staining in null mutant backgrounds, are essential for result interpretation.
RAD-51 foci dynamics in zhp-4 mutants reveal critical insights into ZHP-4's regulatory roles:
| Meiotic Zone | Wild-type | zhp-4(vv103) null | zhp-4(vv96) hypomorph |
|---|---|---|---|
| Zone 3 (TZ/early pach) | Initial appearance | Higher levels (p<0.001) | Higher levels (p<0.001) |
| Zones 4-5 (mid-pach) | Gradual resolution | Elevated (p<0.001) | Elevated (p<0.001) |
| Zone 6 (late pach) | Complete resolution | Wild-type levels (p>0.05) | Remains elevated (p<0.001) |
These patterns suggest ZHP-4 functions in both:
Negatively regulating DSB formation
Facilitating timely resolution of recombination intermediates
Supporting this interpretation, zhp-4(vv103);rad-54(RNAi) double mutants show significantly more RAD-51 foci than rad-54(RNAi) alone (13.5 vs. 9.6, p<0.00001), indicating increased DSB formation rather than defective repair .
Methodologically, these findings were established through:
Immunolocalization of RAD-51 and axis component HTP-3
Quantitative analysis of foci across standardized germline zones
Statistical analysis using Mann-Whitney test
Combined genetic analysis with repair-defective backgrounds (rad-54)
ZHP-4 critically influences the recruitment and stabilization of pro-crossover factors, with distinct effects depending on mutation type:
MSH-5 localization patterns:
Wild-type: Numerous small foci in early/mid-pachytene gradually resolve to ~6 foci per nucleus
zhp-4(vv103) null: No detectable MSH-5 foci at any stage
zhp-4(vv96) hypomorph: Delayed appearance with aberrant morphology; ~10-25 foci of varying sizes persist
COSA-1 localization patterns:
Wild-type: ~6 bright foci at designated crossover sites
zhp-4(vv103) and zhp-4(vv96): Foci of varying intensities that fail to properly localize to chromosome axes
zhp-4(H26A) RING domain mutant: 1-3 foci that do localize to synapsed chromosome axes
| Genotype | COSA-1 foci (median ± IQR) | Localization pattern |
|---|---|---|
| Wild-type | 6 | Bright, axis-associated |
| zhp-4(vv103) | Variable | Weak, diffuse, often off-axis |
| zhp-4(vv96) | Variable | Weak, diffuse, often off-axis |
| zhp-4(H26A) | 1-3 | Axis-associated |
For experimental approaches, researchers should:
Use fluorescently tagged versions of MSH-5 and COSA-1 (e.g., GFP::MSH-5)
Quantify foci at defined meiotic stages (particularly pachytene exit)
Consider size, intensity, and chromosomal association of foci
Statistical comparison using non-parametric tests (Mann-Whitney)
The RING finger domain of ZHP-4 appears critical for its full functionality:
Structural features:
Functional analysis through targeted mutation:
These observations suggest the RING domain is necessary for crossover designation but may be dispensable for some aspects of crossover maturation, potentially indicating separable functions.
For studying RING domain function, researchers should consider:
Site-directed mutagenesis of specific zinc-coordinating residues
Analysis of potential substrates for SUMO modification
In vitro SUMO ligase activity assays with recombinant proteins
Proteomic approaches to identify interaction partners
ZHP-4 and ZHP-3 demonstrate strong reciprocal dependency:
Localization interdependence:
Co-localization patterns:
Structural similarities:
These findings strongly suggest ZHP-4 and ZHP-3 function as a complex during meiosis, with neither protein able to localize or function independently of the other.
Methodologically, researchers investigating this interaction should:
Use co-immunoprecipitation to confirm physical interaction
Generate separation-of-function mutations that disrupt specific interaction interfaces
Employ quantitative imaging to assess co-localization patterns
Consider proteomic approaches to identify additional complex components
Based on the differential phenotypes observed in various zhp-4 mutants, a comprehensive experimental toolkit can be developed:
Targeted mutagenesis:
Time-resolved analysis:
Temporally controlled protein depletion (e.g., auxin-inducible degron system)
Sequential immunostaining at defined stages of meiotic prophase
Live imaging of ZHP-4 dynamics in relation to other crossover proteins
Genetic interaction studies:
Double mutants with early recombination factors (MSH-5) versus late maturation factors
Suppressor screens to identify factors that can bypass ZHP-4 requirement
Analysis in chromosomal contexts that alter crossover distribution (e.g., fusion chromosomes)
Biochemical approaches:
Identification of SUMO targets during meiosis
In vitro reconstitution of ZHP-3/ZHP-4 complexes
Structural studies of protein domains and interaction interfaces
By combining these approaches, researchers can dissect the multiple distinct steps at which ZHP-4 functions during meiotic crossover formation.